HK Stock MarketDetailed Quotes

ENTERPRISE DEV (01808)

Watchlist
  • 1.700
  • -0.200-10.53%
Trading Apr 27 11:04 CST
416.31MMarket Cap2.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ENTERPRISE DEV (01808) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
844.37%3.86B
332.06%551.27M
573.72%408.59M
333.48%127.59M
26.59%60.65M
18.44%29.43M
17.35%47.91M
19.83%24.85M
-42.37%40.83M
-31.83%20.74M
Operating income
844.37%3.86B
332.06%551.27M
573.72%408.59M
333.48%127.59M
26.59%60.65M
18.44%29.43M
17.35%47.91M
19.83%24.85M
-42.37%40.83M
-31.83%20.74M
Cost of sales
-923.22%-3.71B
-417.04%-487.67M
-947.86%-362.57M
-399.94%-94.32M
-27.71%-34.6M
-36.51%-18.87M
-11.43%-27.09M
-1.38%-13.82M
54.35%-24.31M
42.91%-13.63M
Operating expenses
-923.22%-3.71B
-417.04%-487.67M
-947.86%-362.57M
-399.94%-94.32M
-27.71%-34.6M
-36.51%-18.87M
-11.43%-27.09M
-1.38%-13.82M
54.35%-24.31M
42.91%-13.63M
Gross profit
223.06%148.65M
91.16%63.6M
76.67%46.01M
214.84%33.27M
25.12%26.05M
-4.21%10.57M
26.07%20.82M
55.23%11.03M
-6.06%16.51M
8.60%7.11M
Selling expenses
-28.10%-28.08M
-2.18%-8.69M
-37.71%-21.92M
-20.54%-8.5M
-9.97%-15.92M
1.05%-7.06M
13.38%-14.48M
20.37%-7.13M
14.25%-16.71M
4.37%-8.95M
Administrative expenses
5.20%-39.69M
-19.05%-17.32M
-85.48%-41.87M
-47.25%-14.55M
-33.97%-22.57M
-9.46%-9.88M
5.71%-16.85M
9.17%-9.03M
-3.26%-17.87M
-55.29%-9.94M
Revaluation surplus
----
----
----
----
----
153.14%4.16M
-13.03%-9.07M
-32.78%-7.83M
-317.21%-8.03M
-165.71%-5.9M
-Changes in the fair value of financial assets
----
----
----
----
----
153.14%4.16M
-13.03%-9.07M
-32.78%-7.83M
-317.21%-8.03M
-165.71%-5.9M
Impairment and provision
75.17%-481K
----
73.52%-1.94M
----
0.50%-7.31M
----
13.87%-7.35M
----
7.13%-8.54M
----
-Impairment of intangible assets
----
----
----
----
----
----
----
----
82.00%-1.48M
----
-Other impairment is provision
75.17%-481K
----
73.52%-1.94M
----
0.50%-7.31M
----
-4.18%-7.35M
----
-623.69%-7.06M
----
Special items of operating profit
31.41%136.91M
-20.29%12.91M
332.63%104.19M
118.66%16.19M
16,979.43%24.08M
4,156.32%7.41M
-97.22%141K
-94.29%174K
492.63%5.07M
1,779.63%3.05M
Operating profit
157.26%217.31M
91.20%50.5M
1,854.51%84.47M
408.06%26.41M
116.13%4.32M
140.68%5.2M
9.38%-26.79M
12.68%-12.78M
-23.95%-29.56M
-29.80%-14.64M
Financing cost
18.28%-7.51M
-13.06%-4.3M
-900.65%-9.19M
-594.34%-3.81M
-4.68%-918K
-38.73%-548K
-22.66%-877K
-334.07%-395K
41.54%-715K
86.48%-91K
Earning before tax
178.67%209.81M
104.35%46.2M
2,111.75%75.29M
386.11%22.61M
112.30%3.4M
135.30%4.65M
8.62%-27.67M
10.54%-13.17M
-20.75%-30.28M
-23.25%-14.73M
Tax
-917.72%-17.58M
63.98%-1.27M
-535.01%-1.73M
-11,429.03%-3.51M
-85.05%397K
127.19%31K
683.52%2.66M
-150.22%-114K
-84.21%-455K
215.28%227K
After-tax profit from continuing operations
161.32%192.23M
135.30%44.94M
1,835.31%73.56M
307.88%19.1M
115.20%3.8M
135.23%4.68M
18.61%-25.01M
8.35%-13.29M
-21.37%-30.73M
-22.09%-14.5M
Earning after tax
161.32%192.23M
135.30%44.94M
1,835.31%73.56M
307.88%19.1M
115.20%3.8M
135.23%4.68M
18.61%-25.01M
8.35%-13.29M
-21.37%-30.73M
-22.09%-14.5M
Minority profit
4,759.83%40.05M
-4,400.00%-540K
147.11%824K
97.12%-12K
36.31%-1.75M
-5.05%-416K
60.28%-2.75M
84.32%-396K
18.55%-6.91M
15.30%-2.53M
Profit attributable to shareholders
109.23%152.19M
137.98%45.48M
1,210.58%72.74M
274.83%19.11M
124.92%5.55M
139.54%5.1M
6.52%-22.27M
-7.67%-12.89M
-41.51%-23.82M
-34.61%-11.97M
Basic earnings per share
93.46%0.621
102.17%0.186
872.73%0.321
142.11%0.092
112.22%0.033
122.75%0.038
43.40%-0.27
40.14%-0.167
-1,734.62%-0.477
-1,892.86%-0.279
Diluted earnings per share
93.46%0.621
102.17%0.186
872.73%0.321
142.11%0.092
112.22%0.033
122.75%0.038
43.40%-0.27
40.14%-0.167
-1,734.62%-0.477
-1,892.86%-0.279
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
National Health Accounting Firm Co., Ltd.
--
Bofa Certified Public Accountants Co., Ltd.
--
Bofa Certified Public Accountants Co., Ltd.
--
Bofa Certified Public Accountants Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 844.37%3.86B332.06%551.27M573.72%408.59M333.48%127.59M26.59%60.65M18.44%29.43M17.35%47.91M19.83%24.85M-42.37%40.83M-31.83%20.74M
Operating income 844.37%3.86B332.06%551.27M573.72%408.59M333.48%127.59M26.59%60.65M18.44%29.43M17.35%47.91M19.83%24.85M-42.37%40.83M-31.83%20.74M
Cost of sales -923.22%-3.71B-417.04%-487.67M-947.86%-362.57M-399.94%-94.32M-27.71%-34.6M-36.51%-18.87M-11.43%-27.09M-1.38%-13.82M54.35%-24.31M42.91%-13.63M
Operating expenses -923.22%-3.71B-417.04%-487.67M-947.86%-362.57M-399.94%-94.32M-27.71%-34.6M-36.51%-18.87M-11.43%-27.09M-1.38%-13.82M54.35%-24.31M42.91%-13.63M
Gross profit 223.06%148.65M91.16%63.6M76.67%46.01M214.84%33.27M25.12%26.05M-4.21%10.57M26.07%20.82M55.23%11.03M-6.06%16.51M8.60%7.11M
Selling expenses -28.10%-28.08M-2.18%-8.69M-37.71%-21.92M-20.54%-8.5M-9.97%-15.92M1.05%-7.06M13.38%-14.48M20.37%-7.13M14.25%-16.71M4.37%-8.95M
Administrative expenses 5.20%-39.69M-19.05%-17.32M-85.48%-41.87M-47.25%-14.55M-33.97%-22.57M-9.46%-9.88M5.71%-16.85M9.17%-9.03M-3.26%-17.87M-55.29%-9.94M
Revaluation surplus --------------------153.14%4.16M-13.03%-9.07M-32.78%-7.83M-317.21%-8.03M-165.71%-5.9M
-Changes in the fair value of financial assets --------------------153.14%4.16M-13.03%-9.07M-32.78%-7.83M-317.21%-8.03M-165.71%-5.9M
Impairment and provision 75.17%-481K----73.52%-1.94M----0.50%-7.31M----13.87%-7.35M----7.13%-8.54M----
-Impairment of intangible assets --------------------------------82.00%-1.48M----
-Other impairment is provision 75.17%-481K----73.52%-1.94M----0.50%-7.31M-----4.18%-7.35M-----623.69%-7.06M----
Special items of operating profit 31.41%136.91M-20.29%12.91M332.63%104.19M118.66%16.19M16,979.43%24.08M4,156.32%7.41M-97.22%141K-94.29%174K492.63%5.07M1,779.63%3.05M
Operating profit 157.26%217.31M91.20%50.5M1,854.51%84.47M408.06%26.41M116.13%4.32M140.68%5.2M9.38%-26.79M12.68%-12.78M-23.95%-29.56M-29.80%-14.64M
Financing cost 18.28%-7.51M-13.06%-4.3M-900.65%-9.19M-594.34%-3.81M-4.68%-918K-38.73%-548K-22.66%-877K-334.07%-395K41.54%-715K86.48%-91K
Earning before tax 178.67%209.81M104.35%46.2M2,111.75%75.29M386.11%22.61M112.30%3.4M135.30%4.65M8.62%-27.67M10.54%-13.17M-20.75%-30.28M-23.25%-14.73M
Tax -917.72%-17.58M63.98%-1.27M-535.01%-1.73M-11,429.03%-3.51M-85.05%397K127.19%31K683.52%2.66M-150.22%-114K-84.21%-455K215.28%227K
After-tax profit from continuing operations 161.32%192.23M135.30%44.94M1,835.31%73.56M307.88%19.1M115.20%3.8M135.23%4.68M18.61%-25.01M8.35%-13.29M-21.37%-30.73M-22.09%-14.5M
Earning after tax 161.32%192.23M135.30%44.94M1,835.31%73.56M307.88%19.1M115.20%3.8M135.23%4.68M18.61%-25.01M8.35%-13.29M-21.37%-30.73M-22.09%-14.5M
Minority profit 4,759.83%40.05M-4,400.00%-540K147.11%824K97.12%-12K36.31%-1.75M-5.05%-416K60.28%-2.75M84.32%-396K18.55%-6.91M15.30%-2.53M
Profit attributable to shareholders 109.23%152.19M137.98%45.48M1,210.58%72.74M274.83%19.11M124.92%5.55M139.54%5.1M6.52%-22.27M-7.67%-12.89M-41.51%-23.82M-34.61%-11.97M
Basic earnings per share 93.46%0.621102.17%0.186872.73%0.321142.11%0.092112.22%0.033122.75%0.03843.40%-0.2740.14%-0.167-1,734.62%-0.477-1,892.86%-0.279
Diluted earnings per share 93.46%0.621102.17%0.186872.73%0.321142.11%0.092112.22%0.033122.75%0.03843.40%-0.2740.14%-0.167-1,734.62%-0.477-1,892.86%-0.279
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----National Health Accounting Firm Co., Ltd.--Bofa Certified Public Accountants Co., Ltd.--Bofa Certified Public Accountants Co., Ltd.--Bofa Certified Public Accountants Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.62%
Sample Name
Sample Code
 +0.87%
Sample Name
Sample Code
 -0.66%
4
CNOOC
00883
-0.70%
5
SHANGHAI PECHEM
00338
-4.72%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.95%
Sample Name
Sample Code
 +24.19%
Sample Name
Sample Code
 +19.71%
4
Loongson Technology Corporation
688047
+16.34%
5
Ucloud Technology Co., Ltd
688158
+14.47%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -